NASDAQ
Acro Biomedical Co., Ltd. (ACBM) has a fcf yield of -14.73% as of Monday, August 3, 2026. This represents a 3.89% increase compared to its 12-month average of -15.32%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.